MicroRNAs Expression Model Predicts Time to Local Recurrence in Head and Neck Squamous Cell Carcinoma

HERMANOVÁ, Markéta, Parwez AHMAD, Jiří ŠÁNA, Marek SLÁVIK, Tetiana SHATOKHINA and Ondřej SLABÝ. MicroRNAs Expression Model Predicts Time to Local Recurrence in Head and Neck Squamous Cell Carcinoma. In 107th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP). 2018. ISSN 0893-3952.

Basic information

• Original name: MicroRNAs Expression Model Predicts Time to Local Recurrence in Head and Neck Squamous Cell Carcinoma
• Authors: HERMANOVÁ, Markéta (203 Czech Republic, belonging to the institution), Parwez AHMAD (356 India, belonging to the institution), Jiří ŠÁNA (203 Czech Republic, belonging to the institution), Marek SLÁVIK (703 Slovakia, belonging to the institution), Tetiana SHATOKHINA (804 Ukraine, belonging to the institution) and Ondřej SLABÝ (203 Czech Republic, guarantor, belonging to the institution).
• Edition: 107th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP), 2018.

Other information

• Original language: English
• Type of outcome: Conference abstract
• Field of Study: 30200 3.2 Clinical medicine
• Country of publisher: United States of America
• Confidentiality degree: is not subject to a state or trade secret
• Impact factor: Impact factor: 6.365
• RIV identification code: RIV/00216224:14740/18:00106509
• Organization unit: Central European Institute of Technology
• ISSN: 0893-3952
• UT WoS: 000429308603204
• Keywords in English: MicroRNA; Carcinoma
• Tags: rivok
• Tags: International impact

Abstract

The aim of this study was to discover a set of MicroRNAs (Mirnas) which will predict the radiation therapy response in head and neck squamous cell cancer (HNSCC) patients and be able to predict the locoregional control ( LRC) and classify these patients according to the time to local progression.

Links

• LQ1601, research and development project: Name: CEITEC 2020 (Acronym: CEITEC2020)

Investor: Ministry of Education, Youth and Sports of the CR

• NV15-31627A, research and development project: Name: Možnosti molekulárně řízené radikální radioterapie nebo radiochemoterapie dle profilu mikroRNA u pacientů se spinocelulárními karcinomy hlavy a krku.